5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.14▼ | 1.14▼ | 1.13▲ | 1.13▲ | 1.09▲ |
MA10 | 1.14▼ | 1.12▲ | 1.10▲ | 1.13▲ | 1.06▲ |
MA20 | 1.13▲ | 1.10▲ | 1.11▲ | 1.08▲ | 1.15▼ |
MA50 | 1.10▲ | 1.13▲ | 1.14▼ | 1.05▲ | 1.91▼ |
MA100 | 1.12▲ | 1.13▲ | 1.08▲ | 1.19▼ | 2.87▼ |
MA200 | 1.16▼ | 1.08▲ | 1.05▲ | 1.76▼ | 4.77▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | 0.008▲ | 0.006▲ | 0.006▲ | 0.059▲ |
RSI | 60.499▲ | 58.458▲ | 54.193▲ | 54.167▲ | 41.644▼ |
STOCH | 66.667 | 93.234▲ | 90.000▲ | 55.675 | 56.543 |
WILL %R | -100.000▼ | -6.667▲ | -6.667▲ | -50.000 | -55.200 |
CCI | -66.038 | 89.412 | 95.660 | 22.974 | 36.447 |
Wednesday, June 11, 2025 05:00 PM
NASDAQ:ABOS opened at $1.14 on Wednesday. The stock has a market capitalization of $69.05 million, a P/E ratio of -0.83 and a beta of 0.05. The company has a current ratio of 10.43, a quick ratio ...
|
Wednesday, May 14, 2025 04:59 PM
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q1 2025 Earnings Call Transcript May 13, 2025 Acumen Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.48, expectations were $-0.56.
|
Tuesday, May 13, 2025 04:30 AM
ACUMEN PHARMACEUTICALS ($ABOS) posted quarterly earnings results on Tuesday, May 13th. The company reported earnings of -$0.48 per share, beating estimates of -$0.55 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 1.07 | 1.145 | 1.07 | 1.135 | 179,846 |
13/06/25 | 1.10 | 1.12 | 1.06 | 1.07 | 199,300 |
12/06/25 | 1.15 | 1.155 | 1.10 | 1.14 | 171,700 |
11/06/25 | 1.18 | 1.20 | 1.10 | 1.14 | 229,600 |
10/06/25 | 1.27 | 1.27 | 1.17 | 1.18 | 248,237 |
09/06/25 | 1.20 | 1.28 | 1.19 | 1.27 | 461,277 |
06/06/25 | 1.09 | 1.21 | 1.06 | 1.20 | 383,400 |
05/06/25 | 1.09 | 1.09 | 1.035 | 1.07 | 172,461 |
04/06/25 | 1.00 | 1.07 | 1.00 | 1.07 | 245,081 |
03/06/25 | 1.00 | 1.06 | 1.00 | 1.04 | 334,739 |
|
|
||||
|
|
||||
|
|